Transforming the Treatment of Heart Failure
The Corvia® Atrial Shunt is a novel heart failure (HF) therapy specifically designed to reduce the symptoms associated with high pressures in the heart and lungs. It is the world’s first atrial shunt shown to reduce heart failure hospitalizations and to improve quality of life.
Healthcare Professionals
Learn about the Corvia Atrial Shunt, including study results, peer-reviewed publications, and patient identification.
Learn about the Corvia Atrial Shunt, including study results, peer-reviewed publications, and patient identification.
Patients
Has heart failure impacted your quality of life? Learn about a non-surgical treatment called atrial shunting.
Has heart failure impacted your quality of life? Learn about a non-surgical treatment called atrial shunting.
Find an Implanting Center
Find a center that offers the Corvia Atrial Shunt System.
Find a center that offers the Corvia Atrial Shunt System.
550+ Patients
have received the Corvia Atrial Shunt
100+ Hospitals
with Corvia Atrial Shunt experience
17 Countries
in which the Corvia Atrial Shunt has been implanted
7+ Years
post-implant for the first Corvia Atrial Shunt patients
RESPONDER-HF Clinical Study
A clinical trial to confirm the efficacy of the Corvia Atrial Shunt in heart failure patients with EF ≥40%
Clinical Evidence
Review the clinical evidence that supports the safety and effectiveness of the Corvia Atrial Shunt.
In The News
Insights from Drs. Barry Borlaug and Sanjiv Shah, and Profs. Andrew Coats and Gerd Hasenfuß, on the clinical significance of the REDUCE LAP-HF II results.